|
CA2132342A1
(en)
*
|
1992-04-06 |
1993-10-14 |
Kenneth F. Buechler |
Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
|
|
US5470997A
(en)
*
|
1992-04-06 |
1995-11-28 |
Biosite Diagnostics Incorporated |
Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
|
|
CA2096495C
(en)
*
|
1992-06-16 |
2002-07-09 |
Kathy Palmer Ordonez |
Dual analyte immunoassay
|
|
US6037455A
(en)
*
|
1992-11-09 |
2000-03-14 |
Biosite Diagnostics Incorporated |
Propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels
|
|
US5804452A
(en)
*
|
1995-04-27 |
1998-09-08 |
Quidel Corporation |
One step urine creatinine assays
|
|
US5965375A
(en)
*
|
1997-04-04 |
1999-10-12 |
Biosite Diagnostics |
Diagnostic tests and kits for Clostridium difficile
|
|
DE19859912C2
(de)
*
|
1998-12-23 |
2001-06-21 |
Aventis Res & Tech Gmbh & Co |
Testsystem zur Erkennung verschiedener Marker, seine Herstellung sowie Verwendung
|
|
EP1294749A2
(de)
*
|
2000-03-09 |
2003-03-26 |
Heska Corporation |
Rekombinanten antigenen zur bestimmung des immun-zustandes eines tieres
|
|
US20020110843A1
(en)
*
|
2000-05-12 |
2002-08-15 |
Dumas David P. |
Compositions and methods for epitope mapping
|
|
US7981420B2
(en)
|
2000-12-22 |
2011-07-19 |
Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. |
Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
|
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
|
US20030199000A1
(en)
*
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
|
US7632647B2
(en)
|
2001-04-13 |
2009-12-15 |
Biosite Incorporated |
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
|
|
US20040253637A1
(en)
*
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
|
US20040126767A1
(en)
*
|
2002-12-27 |
2004-07-01 |
Biosite Incorporated |
Method and system for disease detection using marker combinations
|
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
|
US20040121350A1
(en)
*
|
2002-12-24 |
2004-06-24 |
Biosite Incorporated |
System and method for identifying a panel of indicators
|
|
US20040203083A1
(en)
*
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
|
EP1322957B1
(de)
*
|
2001-05-04 |
2009-08-12 |
Biosite Incorporated |
Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
|
|
DE10125258A1
(de)
|
2001-05-23 |
2003-01-09 |
November Ag Molekulare Medizin |
Verfahren zur Bestimmung des Bindeverhaltens von an Ziel-Molekülen spezifisch bindenden Liganden
|
|
DE60233949D1
(de)
*
|
2001-08-20 |
2009-11-19 |
Biosite Inc |
Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
|
|
US6780602B2
(en)
*
|
2001-11-01 |
2004-08-24 |
Microbiosystems, Limited Partnership |
Taxonomic identification of pathogenic microorganisms and their toxic proteins
|
|
US7459127B2
(en)
|
2002-02-26 |
2008-12-02 |
Siemens Healthcare Diagnostics Inc. |
Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
|
|
US7094354B2
(en)
|
2002-12-19 |
2006-08-22 |
Bayer Healthcare Llc |
Method and apparatus for separation of particles in a microfluidic device
|
|
US7125711B2
(en)
|
2002-12-19 |
2006-10-24 |
Bayer Healthcare Llc |
Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
|
|
US7341838B2
(en)
|
2003-04-17 |
2008-03-11 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
|
US7435381B2
(en)
|
2003-05-29 |
2008-10-14 |
Siemens Healthcare Diagnostics Inc. |
Packaging of microfluidic devices
|
|
US20040265171A1
(en)
*
|
2003-06-27 |
2004-12-30 |
Pugia Michael J. |
Method for uniform application of fluid into a reactive reagent area
|
|
US7347617B2
(en)
|
2003-08-19 |
2008-03-25 |
Siemens Healthcare Diagnostics Inc. |
Mixing in microfluidic devices
|
|
US20050164238A1
(en)
*
|
2003-09-29 |
2005-07-28 |
Biosite, Inc. |
Methods and compositions for the diagnosis of sepsis
|
|
US20050130243A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Zheng Yi F. |
Assay for entactogens
|
|
US6991911B2
(en)
*
|
2003-12-15 |
2006-01-31 |
Dade Behring Inc. |
Assay for entactogens
|
|
US7022492B2
(en)
*
|
2003-12-15 |
2006-04-04 |
Dade Behring Inc. |
Ecstasy haptens and immunogens
|
|
US7115383B2
(en)
*
|
2004-03-22 |
2006-10-03 |
Dade Behring Inc. |
Assays for amphetamine and methamphetamine
|
|
US7037669B2
(en)
*
|
2004-03-22 |
2006-05-02 |
Dade Behring Inc. |
Assays for amphetamine and methamphetamine using stereospecific reagents
|
|
WO2006031583A2
(en)
*
|
2004-09-09 |
2006-03-23 |
Biosite Incorporated |
Methods and compositions for measuring canine bnp and uses thereof
|
|
US20080050832A1
(en)
*
|
2004-12-23 |
2008-02-28 |
Buechler Kenneth F |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
|
WO2006078813A2
(en)
*
|
2005-01-21 |
2006-07-27 |
Biosite Incorporated |
Arginine analogs, and methods for their synthesis and use
|
|
US7939342B2
(en)
*
|
2005-03-30 |
2011-05-10 |
Kimberly-Clark Worldwide, Inc. |
Diagnostic test kits employing an internal calibration system
|
|
EP1715341B1
(de)
*
|
2005-04-04 |
2008-02-27 |
Micronas Holding GmbH |
Verfahren und Vorrichtung zum Bestimmen der Konzentrationen von mindestens zwei Liganden
|
|
US20070087453A1
(en)
*
|
2005-10-19 |
2007-04-19 |
Council Of Scientific And Industrial Research |
Immuno conjugate and process for preparation thereof
|
|
WO2007028070A2
(en)
*
|
2005-08-30 |
2007-03-08 |
Biosite, Inc. |
Use of soluble flt-1 and its fragments in cardiovascular conditions
|
|
EP1928905B1
(de)
|
2005-09-30 |
2015-04-15 |
AbbVie Deutschland GmbH & Co KG |
Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
|
|
WO2007103568A2
(en)
*
|
2006-03-09 |
2007-09-13 |
Biosite, Inc. |
Methods and compositions for the diagnosis of diseases of the aorta
|
|
EP1845377A1
(de)
|
2006-04-10 |
2007-10-17 |
Micronas GmbH |
Verfahren und Vorrichtung zum Bestimmen der Konzentrationen von Liganden
|
|
US20080118924A1
(en)
*
|
2006-05-26 |
2008-05-22 |
Buechler Kenneth F |
Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
|
|
GB0611116D0
(en)
|
2006-06-06 |
2006-07-19 |
Oxford Genome Sciences Uk Ltd |
Proteins
|
|
ATE528411T1
(de)
|
2006-06-07 |
2011-10-15 |
Otago Innovation Ltd |
Diagnoseverfahren und -marker
|
|
EP2049902A4
(de)
*
|
2006-07-28 |
2010-09-01 |
Biosite Inc |
Vorrichtung und verfahren zur durchführung von rezeptorbindungstests mithilfe magnetischer partikel
|
|
WO2008030122A1
(en)
|
2006-09-07 |
2008-03-13 |
University Of Otago |
Biomarkers
|
|
DE502006005987D1
(de)
*
|
2006-10-20 |
2010-03-11 |
Micronas Holding Gmbh |
Verfahren und Vorrichtung zum Bestimmen der Konzentrationen von Liganden
|
|
WO2008060607A2
(en)
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
|
|
EP2095106B1
(de)
*
|
2006-11-14 |
2013-03-20 |
Alere San Diego, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenarterienstenose
|
|
US8221995B2
(en)
*
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
|
US20090004755A1
(en)
*
|
2007-03-23 |
2009-01-01 |
Biosite, Incorporated |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
|
US7947465B2
(en)
*
|
2007-08-20 |
2011-05-24 |
Bio-Rad Laboratories, Inc. |
Simultaneous assay for determining drugs
|
|
US20090053832A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Link William F |
Simultaneous assay for determining drugs
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
JP2011516038A
(ja)
|
2008-03-12 |
2011-05-26 |
オタゴ イノベーション リミテッド |
バイオマーカー
|
|
AU2009224113B2
(en)
*
|
2008-03-12 |
2013-02-21 |
Otago Innovation Limited |
Biomarkers
|
|
NZ610356A
(en)
|
2008-08-28 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CA2735590A1
(en)
|
2008-08-29 |
2010-03-04 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
NZ607703A
(en)
|
2008-10-21 |
2014-09-26 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
WO2010048347A2
(en)
|
2008-10-21 |
2010-04-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CN102264230B
(zh)
|
2008-11-10 |
2014-12-10 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
|
MX2011005379A
(es)
|
2008-11-22 |
2011-06-09 |
Astute Medical Inc |
Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
|
|
US20100204055A1
(en)
*
|
2008-12-05 |
2010-08-12 |
Bonner-Ferraby Phoebe W |
Autoantibody detection systems and methods
|
|
EP2394166B1
(de)
|
2009-02-06 |
2016-07-13 |
Astute Medical, Inc. |
Verfahren zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
|
EP2393934A4
(de)
|
2009-02-06 |
2012-08-29 |
Astute Medical Inc |
Diagnose und prognose von nierenläsion und niereninsuffizienz
|
|
WO2011006119A2
(en)
|
2009-07-09 |
2011-01-13 |
The Scripps Research Institute |
Gene expression profiles associated with chronic allograft nephropathy
|
|
CA2770393A1
(en)
|
2009-08-07 |
2011-02-10 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CA2770382A1
(en)
|
2009-08-07 |
2011-02-10 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
NZ598712A
(en)
|
2009-08-28 |
2014-05-30 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EA201290106A1
(ru)
|
2009-09-18 |
2012-12-28 |
Астьют Медикал, Инк. |
Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
|
|
NZ630277A
(en)
|
2009-09-21 |
2015-02-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP2496942B1
(de)
|
2009-11-07 |
2017-03-22 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
|
CA2779905A1
(en)
|
2009-11-07 |
2011-05-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
MX2012006560A
(es)
|
2009-12-08 |
2012-10-05 |
Abbott Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
|
|
JP5763098B2
(ja)
|
2009-12-20 |
2015-08-12 |
アスチュート メディカル，インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
|
PT2666872T
(pt)
|
2010-02-05 |
2016-07-08 |
Astute Medical Inc |
Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
|
|
AU2011213685B2
(en)
|
2010-02-05 |
2014-10-30 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP2531622B1
(de)
|
2010-02-05 |
2016-04-06 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
|
EP3070474A3
(de)
|
2010-02-26 |
2016-12-07 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
|
IN2012MN02812A
(de)
|
2010-06-23 |
2015-05-22 |
Astute Medical Inc |
|
|
EP2899545B1
(de)
|
2010-06-23 |
2018-08-22 |
Astute Medical, Inc. |
Verfahren zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
|
NZ605698A
(en)
|
2010-06-23 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
DK2596010T3
(en)
|
2010-07-19 |
2017-07-31 |
Otago Innovation Ltd |
SIGNAL biomarkers
|
|
EA201390294A1
(ru)
|
2010-09-24 |
2013-09-30 |
Астьют Медикал, Инк. |
Способы и композиции для оценки повреждения почек с применением гиалуроновой кислоты
|
|
US10557856B2
(en)
|
2010-09-24 |
2020-02-11 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Biomarkers of renal injury
|
|
CA2811438A1
(en)
|
2010-10-07 |
2012-04-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CN103370619B
(zh)
|
2010-11-29 |
2016-01-20 |
美艾利尔圣地亚哥有限公司 |
诊断或风险预测心力衰竭的方法和试剂
|
|
CA2824434A1
(en)
|
2011-01-08 |
2012-07-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP2668497B1
(de)
|
2011-01-26 |
2020-03-25 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Urinbiomarker zur vorhersage der erholung nach einer akuten nierenverletzung: proteomik
|
|
EP2668499A4
(de)
|
2011-01-29 |
2015-05-27 |
Astute Medical Inc |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
|
CN103874923B
(zh)
|
2011-08-26 |
2016-09-14 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
|
EP3282257A1
(de)
|
2011-11-22 |
2018-02-14 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
|
ES2734494T3
(es)
|
2011-12-08 |
2019-12-10 |
Astute Medical Inc |
Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal
|
|
CA2855570A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
CA3204283A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
EP3369746A1
(de)
|
2012-01-27 |
2018-09-05 |
AbbVie Deutschland GmbH & Co KG |
Zusammensetzung und verfahren zur diagnose und behandlung von krankheiten im zusammenhang mit neuritenabbau
|
|
EP2820419B1
(de)
|
2012-02-27 |
2020-12-09 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
|
AU2013231230A1
(en)
|
2012-03-13 |
2014-08-07 |
AbbVie Deutschland GmbH & Co. KG |
Method for selecting or identifying a subject for V1B antagonist therapy
|
|
US10114028B2
(en)
|
2012-03-20 |
2018-10-30 |
Upstream Medical Technologies Limited |
Biomarkers for pneumonia and acute decompensated heart failure
|
|
EP2834638B1
(de)
|
2012-04-02 |
2020-02-12 |
Astute Medical, Inc. |
Verfahren zur diagnose und prognose von sepsis
|
|
WO2013163345A1
(en)
|
2012-04-24 |
2013-10-31 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
|
|
WO2014018464A1
(en)
|
2012-07-23 |
2014-01-30 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of sepsis
|
|
WO2014028339A1
(en)
|
2012-08-11 |
2014-02-20 |
Astute Medical, Inc. |
Evaluating renal injury using hyaluronic acid
|
|
TR201807542T4
(tr)
|
2013-01-17 |
2018-06-21 |
Astute Medical Inc |
Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler.
|
|
CN105916860A
(zh)
|
2013-03-14 |
2016-08-31 |
美艾利尔圣地亚哥公司 |
6-单乙酰吗啡类似物的合成和使用方法
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
CN105556305A
(zh)
|
2013-06-05 |
2016-05-04 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
|
EP3617234A1
(de)
|
2013-08-07 |
2020-03-04 |
Astute Medical, Inc. |
Tests auf timp2 mit verbesserter leistung bei biologischen proben
|
|
EP4736949A2
(de)
|
2013-08-23 |
2026-05-06 |
Reata Pharmaceuticals Holdings, LLC |
Verfahren zur behandlung und vorbeugung einer endothelfehlfunktion unter verwendung von bardoxolonmethyl oder analogen davon
|
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
|
WO2015179773A1
(en)
|
2014-05-22 |
2015-11-26 |
The Scripps Research Institute |
Tissue molecular signatures of kidney transplant rejections
|
|
EP3047270A4
(de)
|
2013-09-20 |
2017-07-19 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von appendizitis und differenzierung von ursachen für bauchschmerzen
|
|
US9822172B2
(en)
|
2013-11-06 |
2017-11-21 |
Astute Medical, Inc. |
Assays for IGFBP7 having improved performance in biological samples
|
|
US10300108B2
(en)
|
2013-12-03 |
2019-05-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP3090067B1
(de)
|
2013-12-30 |
2020-07-22 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. |
Genomische neuanordnungen im zusammenhang mit prostatakrebs und verfahren zur verwendung davon
|
|
AU2015263998A1
(en)
|
2014-05-22 |
2016-12-08 |
Northwestern University |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
|
US10443100B2
(en)
|
2014-05-22 |
2019-10-15 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
|
EP3146076A4
(de)
|
2014-05-22 |
2018-05-09 |
The Scripps Research Institute |
Mit subklinischer nierentransplantatabstossung assoziierte genexpressionsprofile
|
|
US11104951B2
(en)
|
2014-05-22 |
2021-08-31 |
The Scripps Research Institute |
Molecular signatures for distinguishing liver transplant rejections or injuries
|
|
GB2528657B
(en)
*
|
2014-07-24 |
2019-03-13 |
Intelligent Fingerprinting Ltd |
Sample analysing device
|
|
CN107003301B
(zh)
|
2014-10-20 |
2019-11-01 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
|
US10473671B2
(en)
|
2014-12-18 |
2019-11-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US11243202B2
(en)
|
2015-04-09 |
2022-02-08 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
HK1249467A1
(zh)
|
2015-05-12 |
2018-11-02 |
阿斯图特医药公司 |
用於肾损伤和肾衰竭的诊断和预後的方法和组合物
|
|
CN107709993A
(zh)
|
2015-06-11 |
2018-02-16 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断和预后的方法和组合物
|
|
US20180224466A1
(en)
|
2015-06-17 |
2018-08-09 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
|
|
AU2016291558A1
(en)
|
2015-07-10 |
2018-02-08 |
West Virginia University |
Markers of stroke and stroke severity
|
|
EP3359558B1
(de)
|
2015-10-06 |
2023-12-13 |
Bio-Rad Laboratories, Inc. |
Immunoassays für borrelia und materialien dafür
|
|
CA3024622A1
(en)
|
2016-05-18 |
2017-11-23 |
Alere San Diego, Inc. |
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use
|
|
EP3465201A4
(de)
|
2016-06-06 |
2020-08-26 |
Astute Medical, Inc. |
Verwaltung von akuter nierenverletzung mit insulinähnlichem wachstumsfaktorbindendem protein 7 und gewebehemmer der metalloproteinase 2
|
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
|
CN110383068A
(zh)
|
2016-10-03 |
2019-10-25 |
雅培实验室 |
评估患者样品中uch-l1状态的改进方法
|
|
WO2018067730A1
(en)
|
2016-10-04 |
2018-04-12 |
University Of Maryland, Baltimore |
Methods of treating sepsis using anti-sepsis lipid a (asla) based therapeutics
|
|
CN110198718B
(zh)
|
2016-11-08 |
2023-01-10 |
里亚塔医药控股有限责任公司 |
使用甲基巴多索隆或其类似物治疗阿尔波特综合征的方法
|
|
JP2020504157A
(ja)
|
2017-01-12 |
2020-02-06 |
アスチュート メディカル，インコーポレイテッド |
Ｃ−ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物
|
|
EP3593134A1
(de)
|
2017-03-09 |
2020-01-15 |
Cleara Biotech B.V. |
Biomarker für zellalterung
|
|
CA3261113A1
(en)
|
2017-03-23 |
2025-10-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
|
WO2018191531A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
|
ES3053676T3
(en)
|
2017-04-28 |
2026-01-23 |
Abbott Lab |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
WO2018208684A1
(en)
|
2017-05-07 |
2018-11-15 |
Astute Medical, Inc. |
Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy
|
|
US10866251B2
(en)
|
2017-05-25 |
2020-12-15 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
|
JP7269182B2
(ja)
|
2017-05-30 |
2023-05-08 |
アボット・ラボラトリーズ |
心臓トロポニンｉ及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法
|
|
US11169159B2
(en)
|
2017-07-03 |
2021-11-09 |
Abbott Laboratories |
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
|
|
EP3721233A2
(de)
|
2017-12-09 |
2020-10-14 |
Abbott Laboratories |
Verfahren zur unterstützung bei der diagnose und bewertung eines patienten, der eine orthopädische verletzung erlitten hat und der eine verletzung des kopfes wie eine leichte traumatische hirnverletzung (tbi) hat oder möglicherweise erlitten hat, unter verwendung eines glialen fibrillären sauren proteins (gfap) und/oder einer ubiquitin-carboxy-terminalen hydrolase l1 (uch-l1)
|
|
JP7379165B2
(ja)
|
2017-12-09 |
2023-11-14 |
アボット・ラボラトリーズ |
Ｇｆａｐとｕｃｈ－ｌ１との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法
|
|
US11891439B2
(en)
|
2017-12-28 |
2024-02-06 |
Astute Medical, Inc. |
Antibodies and assays for CCL14
|
|
CN111699391A
(zh)
|
2017-12-29 |
2020-09-22 |
雅培实验室 |
用于诊断和评估创伤性脑损伤的新型生物标志物和方法
|
|
EP3759213B1
(de)
|
2018-03-02 |
2026-04-29 |
Quantumcyte, Inc. |
Verfahren, zusammensetzungen und vorrichtungen zur isolierung und expressionsanalyse von interessierenden regionen aus einem gewebe
|
|
WO2019213619A1
(en)
|
2018-05-04 |
2019-11-07 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
|
WO2020051231A1
(en)
|
2018-09-04 |
2020-03-12 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Use of delta-tocotrienol for treating cancer
|
|
US12061200B2
(en)
|
2018-12-28 |
2024-08-13 |
Abbott Laboratories |
Direct detection of single molecules on microparticles
|
|
WO2020144535A1
(en)
|
2019-01-08 |
2020-07-16 |
Aduro Biotech Holdings, Europe B.V. |
Methods and compositions for treatment of multiple myeloma
|
|
EP3931573A1
(de)
|
2019-03-01 |
2022-01-05 |
Abbott Laboratories |
Verfahren zur vorhersage von schwerwiegenden kardiovaskulären ereignissen bei patienten mit koronararterienerkrankung
|
|
US12582726B1
(en)
|
2019-04-05 |
2026-03-24 |
Earli Inc. |
Synthetic cancer-specific promoters
|
|
JP2022527629A
(ja)
|
2019-04-05 |
2022-06-02 |
アーリー・インコーポレイテッド |
合成バイオマーカーのための改良された方法及び組成物
|
|
EP4136459A1
(de)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Verfahren, komplexe und kits zum nachweis oder zur bestimmung einer menge eines ss-coronavirus-antikörpers in einer probe
|
|
BR112022022599A2
(pt)
|
2020-05-09 |
2023-03-21 |
Reata Pharmaceuticals Holdings Llc |
Métodos de tratamento de covid-19 usando bardoxolona metil ou análogos da mesma
|
|
KR20230012539A
(ko)
|
2020-05-13 |
2023-01-26 |
디스크 메디슨, 인크. |
골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체
|
|
EP4158352A1
(de)
|
2020-06-01 |
2023-04-05 |
Loop Diagnostics, S.L. |
Verfahren und kit zum frühen nachweis von sepsis
|
|
CA3188349A1
(en)
|
2020-08-04 |
2022-02-10 |
A. Scott Muerhoff |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
|
US11988671B2
(en)
|
2020-08-04 |
2024-05-21 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting SARS-CoV-2
|
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
AU2021397631A1
(en)
|
2020-12-11 |
2023-07-20 |
Reata Pharmaceuticals Holdings, LLC |
Synthetic triterpenoids for use in therapy
|
|
EP4271998A1
(de)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Verfahren zur bestimmung des sars-cov-2-antigens und anti-sars-cov-2-antikörpers in einer probe
|
|
US20220381796A1
(en)
|
2021-05-18 |
2022-12-01 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
|
WO2022266034A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
|
EP4392783A1
(de)
|
2021-08-27 |
2024-07-03 |
Abbott Laboratories |
Verfahren zum nachweis von immunoglobulin g, subklassen 4 (igg4) in einer biologischen probe
|
|
CN118715440A
(zh)
|
2021-08-31 |
2024-09-27 |
雅培实验室 |
诊断脑损伤的方法和系统
|
|
JP2024534849A
(ja)
|
2021-08-31 |
2024-09-26 |
アボット・ラボラトリーズ |
脳の損傷を診断する方法及びシステム
|
|
JP2024538608A
(ja)
|
2021-09-30 |
2024-10-23 |
アボット・ラボラトリーズ |
脳の損傷を診断する方法及びシステム
|
|
EP4448179A1
(de)
|
2021-12-17 |
2024-10-23 |
Abbott Laboratories |
Systeme und verfahren zur bestimmung von uch-l1, gfap und anderen biomarkern in blutproben
|
|
JP2025503207A
(ja)
|
2022-01-27 |
2025-01-30 |
サノフィ・パスツール |
修飾されたＶｅｒｏ細胞、及びウイルス産生にこれを使用する方法
|
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
|
KR20250018169A
(ko)
|
2022-04-29 |
2025-02-04 |
브로드윙 바이오 엘엘씨 |
이중특이적 항체 및 안구 질환의 치료 방법
|
|
US20250296996A1
(en)
|
2022-04-29 |
2025-09-25 |
Broadwing Bio, Inc. |
Angiopoietin-related protein 7-specific antibodies and uses thereof
|
|
EP4514844A1
(de)
|
2022-04-29 |
2025-03-05 |
Broadwing Bio LLC |
Komplementfaktor-h-verwandte 4-spezifische antikörper und verwendungen davon
|
|
EP4587840A1
(de)
|
2022-09-15 |
2025-07-23 |
Abbott Laboratories |
Hbv-diagnostische, prognostische und therapeutische verfahren und produkte
|
|
JP2025532597A
(ja)
|
2022-09-15 |
2025-10-01 |
アボット・ラボラトリーズ |
軽度及び超軽度の外傷性脳損傷を区別するためのバイオマーカー及び方法
|
|
EP4658687A1
(de)
|
2023-01-31 |
2025-12-10 |
University of Rochester |
Immuncheckpoint-blockadetherapie zur behandlung von staphylococcus-aureus-infektionen
|
|
WO2024211475A1
(en)
|
2023-04-04 |
2024-10-10 |
Abbott Laboratories |
Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
|
|
EP4713682A1
(de)
|
2023-04-28 |
2026-03-25 |
Abbott Point of Care Inc. |
Verbesserte tests, kartuschen und kits zum nachweis von biomarkern, einschliesslich biomarkern für hirnverletzungen
|
|
WO2024227154A1
(en)
|
2023-04-28 |
2024-10-31 |
Broadwing Bio Llc |
Complement component 3 (c3)-specific antibodies and uses thereof
|
|
WO2024231728A2
(en)
|
2023-05-05 |
2024-11-14 |
Bio-Rad Abd Serotec Gmbh |
Spycatcher analogs and uses thereof
|
|
US12122842B1
(en)
|
2023-09-27 |
2024-10-22 |
R&D Systems, Inc. |
Human CD30-specific binding proteins and uses thereof
|
|
WO2025111147A1
(en)
|
2023-11-21 |
2025-05-30 |
Abbott Laboratories |
Two-dimensional matrix droplet array
|
|
WO2026024666A1
(en)
|
2024-07-22 |
2026-01-29 |
Abbott Laboratories |
Systems and methods for digital detection assays
|
|
WO2026024668A1
(en)
|
2024-07-22 |
2026-01-29 |
Abbott Laboratories |
Method of determining a volume of a liquid in a sample
|
|
WO2026024677A1
(en)
|
2024-07-22 |
2026-01-29 |
Abbott Laboratories |
Method for determining the plasma volume of a blood sample and method for determining the dilution of plasma
|